Speaker illustration

Doctor Yehuda Handelsman

The Metabolic Institute of America, Tarzana (United States of America)

The impact of dronedarone on patients with atrial fibrillation and diabetes - A sub-analysis of the ATHENA and EURIDIS/ADONIS trials

Event: ESC Congress 2021 - The Digital Experience

Topic: Rhythm Control, Antiarrhythmic Drugs

Session: Atrial fibrillation e-posters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb